{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:47:32Z","timestamp":1793447252472,"version":"4.5.0"},"reference-count":91,"publisher":"American Medical Association (AMA)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2025,12,2]]},"abstract":"<jats:sec id=\"ab-jrv250029-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>\n                      Syphilis is an infectious disease caused by\n                      <jats:italic toggle=\"yes\">Treponema pallidum<\/jats:italic>\n                      , a gram-negative, spirochete bacterium. Worldwide, an estimated 8 million adults aged 18 to 49 years acquired syphilis in 2022. From 2019 to 2023, US syphilis cases increased by 61% overall, with diagnoses among females increasing by 112% and congenital syphilis cases increasing by 106%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv250029-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>\n                      Syphilis is transmitted via contact with infectious lesions during vaginal, anal, or oral sex or via the placenta during pregnancy. Individuals at increased risk for syphilis include people with HIV, those engaging in condomless sex with multiple partners, and men who have sex with men (MSM)\u2014who comprised one-third (32.7%) of all males with primary and secondary syphilis in 2023. Early syphilis is defined as syphilis in the first year after infection and includes symptomatic (primary and secondary) and asymptomatic (early latent) stages. Primary syphilis is characterized by painless anogenital lesions. Secondary syphilis is associated with a diffuse rash, mucocutaneous lesions, and lymphadenopathy. Syphilis diagnosed more than a year after infection is referred to as\n                      <jats:italic toggle=\"yes\">late syphilis<\/jats:italic>\n                      and includes asymptomatic (late latent) and symptomatic (tertiary) stages. Neurosyphilis, which can occur at any stage, can lead to meningitis, uveitis, hearing loss, or stroke. In pregnancy, up to 40% of fetuses with in-utero exposure to syphilis are stillborn or die from their infection during infancy. The diagnosis of syphilis relies on serologic reactivity along with a clinical history and presentation consistent with active or latent syphilis infection. The recommended treatment for syphilis is benzathine penicillin G administered as intramuscular doses of 2.4 million units: a single injection for early stage and 3 weekly injections for late latent stage syphilis. Strategies to identify and prevent syphilis infections include (1) screening of sexually active people aged 15 to 44 years at least once and at least annually for those at increased risk, (2) screening 3 times in pregnant individuals (at the first prenatal visit, during the third trimester, and at delivery), (3) counseling about condom use, and (4) offering doxycycline postexposure prophylaxis (200-mg doxycycline taken within 72 hours after sex as postexposure prophylaxis) to MSM and transgender women with a history of a sexually transmitted infection in the past year.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv250029-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Syphilis infections, including congenital syphilis, have increased in the US and worldwide over the past decade. First-line treatment for syphilis is benzathine penicillin G. Routine syphilis screening of all pregnant patients and all sexually active people aged 15 to 44 years and use of doxycycline postexposure prophylaxis in individuals at risk for syphilis infection are recommended strategies to decrease syphilis transmission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2025.17362","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:00:59Z","timestamp":1760626859000},"page":"1927","source":"Crossref","is-referenced-by-count":58,"title":["Syphilis"],"prefix":"10.1001","volume":"334","author":[{"given":"Franco J.","family":"Chevalier","sequence":"first","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California"},{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Bacon","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California"},{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Cohen","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California"},{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"jrv250029r1","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/children10081310","article-title":"Congenital syphilis: an illustrative review.","volume":"10","author":"Sankaran","year":"2023","journal-title":"Children (Basel)"},{"issue":"46","key":"jrv250029r5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.15585\/mmwr.mm7246e1","article-title":"Vital signs: missed opportunities for preventing congenital syphilis: United States, 2022.","volume":"72","author":"McDonald","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"jrv250029r6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/pathogens11050547","article-title":"Geospatial social determinants of health correlate with disparities in syphilis and congenital syphilis cases in California.","volume":"11","author":"Johnson","year":"2022","journal-title":"Pathogens"},{"issue":"6","key":"jrv250029r8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jinf.2022.04.024","article-title":"Infection risk in sexual contacts of syphilis: a systematic review and meta-analysis.","volume":"84","author":"Denman","year":"2022","journal-title":"J Infect"},{"issue":"9","key":"jrv250029r9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1056\/NEJMra1901593","article-title":"The modern epidemic of syphilis.","volume":"382","author":"Ghanem","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"jrv250029r10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaad.2019.02.074","article-title":"Sexually acquired syphilis: laboratory diagnosis, management, and prevention.","volume":"82","author":"Forrestel","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"jrv250029r11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/sti.65.1.1","article-title":"Primary and secondary syphilis, 20 years\u2019 experience: 2. clinical features.","volume":"65","author":"Mindel","year":"1989","journal-title":"Genitourin Med"},{"issue":"10078","key":"jrv250029r12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(16)32411-4","article-title":"Syphilis.","volume":"389","author":"Hook","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"jrv250029r13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1128\/CMR.18.1.205-216.2005","article-title":"Secondary syphilitic lesions.","volume":"18","author":"Baughn","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"jrv250029r14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40257-022-00755-3","article-title":"Syphilis in dermatology: recognition and management.","volume":"24","author":"Whiting","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"suppl 34","key":"jrv250029r15","first-page":"3","article-title":"The Oslo study of untreated syphilis; an epidemiologic investigation of the natural course of the syphilitic infection based upon a re-study of the Boeck-Bruusgaard material.","volume":"35","author":"Gjestland","year":"1955","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"issue":"1","key":"jrv250029r16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5114\/ceh.2024.136235","article-title":"Syphilitic hepatitis.","volume":"10","author":"Supronowicz","year":"2024","journal-title":"Clin Exp Hepatol"},{"issue":"7","key":"jrv250029r17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/imj.15407","article-title":"Renal manifestations of syphilis.","volume":"51","author":"Shettigar","year":"2021","journal-title":"Intern Med J"},{"issue":"1","key":"jrv250029r19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/OLQ.0000000000000899","article-title":"Trends in deaths due to syphilis, United States, 1968-2015.","volume":"46","author":"Peterman","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"17","key":"jrv250029r20","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1093\/eurheartj\/ehae183","article-title":"Syphilis and cardiovascular risk: a Taiwanese registry.","volume":"45","author":"Wu","year":"2024","journal-title":"Eur Heart J"},{"issue":"5","key":"jrv250029r21","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1093\/cid\/ciad437","article-title":"State-of-the-art review: neurosyphilis.","volume":"78","author":"Hamill","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"14","key":"jrv250029r22","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJMra1906228","article-title":"Neurosyphilis.","volume":"381","author":"Ropper","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"jrv250029r23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jama.2025.4358","article-title":"Uveitis in adults: a review.","volume":"334","author":"Maghsoudlou","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"jrv250029r24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/OLQ.0000000000001155","article-title":"Otosyphilis: a review of the literature.","volume":"47","author":"Ramchandani","year":"2020","journal-title":"Sex Transm Dis"},{"issue":"43","key":"jrv250029r25","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.15585\/mmwr.mm6543a2","article-title":"Ocular syphilis: eight jurisdictions, United States, 2014-2015.","volume":"65","author":"Oliver","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"jrv250029r26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/sti.2010.043042","article-title":"Ocular syphilis among HIV-infected patients: a systematic analysis of the literature.","volume":"87","author":"Tucker","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"1","key":"jrv250029r27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000079391","article-title":"Current clinical spectrum of neurosyphilis in immunocompetent patients.","volume":"52","author":"Conde-Send\u00edn","year":"2004","journal-title":"Eur Neurol"},{"issue":"2","key":"jrv250029r28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.idc.2023.02.006","article-title":"Syphilis.","volume":"37","author":"Ramchandani","year":"2023","journal-title":"Infect Dis Clin North Am"},{"key":"jrv250029r29","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1093\/cid\/ciaa306","article-title":"Syphilis laboratory guidelines: performance characteristics of nontreponemal antibody tests.","volume":"71","author":"Tuddenham","year":"2020","journal-title":"Clin Infect Dis"},{"key":"jrv250029r31","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00572-19","article-title":"Treponema pallidum nucleic acid amplification testing to augment syphilis screening among men who have sex with men.","author":"Golden","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"3","key":"jrv250029r32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/sextrans-2012-050622","article-title":"Sensitivity, specificity and likelihood ratios of PCR in the diagnosis of syphilis: a systematic review and meta-analysis.","volume":"89","author":"Gayet-Ageron","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"1","key":"jrv250029r33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3201\/eid2101.140790","article-title":"Use of Treponema pallidum PCR in testing of ulcers for diagnosis of primary syphilis.","volume":"21","author":"Gayet-Ageron","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"jrv250029r34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2202762","article-title":"Syphilis complicating pregnancy and congenital syphilis.","author":"Stafford","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"jrv250029r35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.2024.10505","article-title":"Two-stage syphilis testing.","volume":"332","author":"Lopes Almeida Gomes","year":"2024","journal-title":"JAMA"},{"issue":"14","key":"jrv250029r36","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1177\/0961203316640912","article-title":"Systematic review of case reports of antiphospholipid syndrome following infection.","volume":"25","author":"Abdel-Wahab","year":"2016","journal-title":"Lupus"},{"issue":"1","key":"jrv250029r37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7301a1","article-title":"CDC laboratory recommendations for syphilis testing, United States, 2024.","volume":"73","author":"Papp","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"jrv250029r38","doi-asserted-by":"publisher","first-page":"17073","DOI":"10.1038\/nrdp.2017.73","article-title":"Syphilis.","volume":"3","author":"Peeling","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"jrv250029r39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2006.12.024","article-title":"Characterization of the Western blotting IgG reactivity patterns in the clinical phases of acquired syphilis.","volume":"58","author":"de Lemos","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"jrv250029r40","first-page":"5","article-title":"Detection of specific IgM-CLASS antitreponemal antibodies in blood serum of patients with syphilis with the use of CAPTIA Syphilis-M reaction and comparing it with VDRL, FTA-ABS and TPHA reactions.","author":"Gibowski","year":"1998","journal-title":"Med Sci Monit"},{"issue":"9","key":"jrv250029r41","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1258\/ijsa.2008.008103","article-title":"Qualitative and quantitative aspects of the serological diagnosis of early syphilis.","volume":"19","author":"McMillan","year":"2008","journal-title":"Int J STD AIDS"},{"issue":"12","key":"jrv250029r42","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1097\/OLQ.0b013e3181124473","article-title":"An evaluation of the relative sensitivities of the venereal disease research laboratory test and the Treponema pallidum particle agglutination test among patients diagnosed with primary syphilis.","volume":"34","author":"Creegan","year":"2007","journal-title":"Sex Transm Dis"},{"issue":"4","key":"jrv250029r44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021.","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"jrv250029r45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/jama.2021.23487","article-title":"Diagnosis and treatment of sexually transmitted infections: a review.","volume":"327","author":"Tuddenham","year":"2022","journal-title":"JAMA"},{"issue":"8","key":"jrv250029r46","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1086\/656419","article-title":"Jarisch-Herxheimer reaction after penicillin therapy among patients with syphilis in the era of the HIV infection epidemic: incidence and risk factors.","volume":"51","author":"Yang","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"jrv250029r47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000458761","article-title":"Phototoxicity of doxycycline: a systematic review on clinical manifestations, frequency, cofactors, and prevention.","volume":"30","author":"Goetze","year":"2017","journal-title":"Skin Pharmacol Physiol"},{"issue":"5","key":"jrv250029r48","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/OLQ.0b013e318249968c","article-title":"Treatment of late syphilis with 2.4 million units benzathine penicillin G (BPG): tolerance of single versus divided doses.","volume":"39","author":"Janier","year":"2012","journal-title":"Sex Transm Dis"},{"issue":"1","key":"jrv250029r49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11904-025-00728-1","article-title":"Point-of-care syphilis testing: implementation and future direction.","volume":"22","author":"Chan","year":"2025","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"4","key":"jrv250029r50","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.amepre.2019.11.010","article-title":"Availability of safety-net sexually transmitted disease clinical services in the U.S., 2018.","volume":"58","author":"Leichliter","year":"2020","journal-title":"Am J Prev Med"},{"key":"jrv250029r52","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1093\/cid\/ciaa349","article-title":"Sensitivity and specificity of treponemal-specific tests for the diagnosis of syphilis.","volume":"71","author":"Park","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"jrv250029r53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/OLQ.0000000000002108","article-title":"ASTDA Position Paper: alternatives to benzathine penicillin G for the treatment of syphilis during pregnancy.","volume":"52","author":"Batteiger","year":"2025","journal-title":"Sex Transm Dis"},{"issue":"18","key":"jrv250029r54","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1001\/jama.2014.13259","article-title":"Treatment of syphilis: a systematic review.","volume":"312","author":"Clement","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"jrv250029r55","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/jdv.16946","article-title":"2020 European guideline on the management of syphilis.","volume":"35","author":"Janier","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"jrv250029r56","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update.","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"jrv250029r57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1473-3099(23)00693-X","article-title":"Repurposing antibiotics to treat syphilis.","volume":"24","author":"Stafylis","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"jrv250029r58","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1473-3099(23)00683-7","article-title":"Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial.","volume":"24","author":"Ubals","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"jrv250029r59","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/cid\/ciab187","article-title":"Clinical efficacy of cefixime for the treatment of early syphilis.","volume":"73","author":"Stafylis","year":"2021","journal-title":"Clin Infect Dis"},{"key":"jrv250029r60","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12879-015-1209-0","article-title":"A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non-responsiveness and the serofast state after therapy.","volume":"15","author":"Se\u00f1a","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"1","key":"jrv250029r61","doi-asserted-by":"publisher","first-page":"15456","DOI":"10.1038\/s41598-017-15641-w","article-title":"Incidence of asymptomatic neurosyphilis in serofast Chinese syphilis patients.","volume":"7","author":"Cai","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"jrv250029r63","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/cid\/cit146","article-title":"Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda.","volume":"56","author":"Dionne-Odom","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"11","key":"jrv250029r64","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/cid\/cir671","article-title":"Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis.","volume":"53","author":"Se\u00f1a","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"jrv250029r65","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/cid\/cis918","article-title":"Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin.","volume":"56","author":"Se\u00f1a","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"jrv250029r66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/antibiotics8020047","article-title":"Penicillin G sodium as a treatment of otosyphilis with hearing loss.","volume":"8","author":"Chotmongkol","year":"2019","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"jrv250029r67","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/jdv.16347","article-title":"The importance of proper and prompt treatment of ocular syphilis: a lesson from permanent vision loss in 52 eyes.","volume":"34","author":"Gu","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"jrv250029r68","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2105\/AJPH.2011.300383","article-title":"Repeat syphilis among men who have sex with men in California, 2002-2006: implications for syphilis elimination efforts.","volume":"102","author":"Cohen","year":"2012","journal-title":"Am J Public Health"},{"issue":"3","key":"jrv250029r69","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/lgbt.2016.0095","article-title":"Rates and correlates of syphilis reinfection in men who have sex with men.","volume":"4","author":"Jain","year":"2017","journal-title":"LGBT Health"},{"issue":"5","key":"jrv250029r70","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/OLQ.0b013e3181ca3c0a","article-title":"Frequent testing of highly sexually active gay men is required to control syphilis.","volume":"37","author":"Gray","year":"2010","journal-title":"Sex Transm Dis"},{"issue":"12","key":"jrv250029r71","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1001\/jama.2022.15322","article-title":"Screening for syphilis infection in nonpregnant adolescents and adults: US Preventive Services Task Force Reaffirmation Recommendation Statement.","volume":"328","author":"Mangione","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"jrv250029r72","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/OLQ.0000000000001518","article-title":"Effectiveness of syphilis partner notification after adjusting for treatment dates, 7 jurisdictions.","volume":"49","author":"Cope","year":"2022","journal-title":"Sex Transm Dis"},{"issue":"9","key":"jrv250029r73","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2018.7769","article-title":"Screening for syphilis infection in pregnant women: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"320","author":"Lin","year":"2018","journal-title":"JAMA"},{"issue":"7","key":"jrv250029r74","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/OLQ.0b013e3181a396eb","article-title":"A systematic review of epidemiologic studies assessing condom use and risk of syphilis.","volume":"36","author":"Koss","year":"2009","journal-title":"Sex Transm Dis"},{"issue":"7","key":"jrv250029r75","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2020.13095","article-title":"Behavioral counseling interventions to prevent sexually transmitted infections: US Preventive Services Task Force Recommendation Statement.","volume":"324","author":"Krist","year":"2020","journal-title":"JAMA"},{"issue":"22","key":"jrv250029r77","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1001\/jama.2025.5009","article-title":"Screening for syphilis infection during pregnancy: US Preventive Services Task Force reaffirmation recommendation statement.","volume":"333","author":"Silverstein","year":"2025","journal-title":"JAMA"},{"issue":"14","key":"jrv250029r78","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure doxycycline to prevent bacterial sexually transmitted infections.","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"N Engl J Med"},{"issue":"14","key":"jrv250029r79","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jama.2023.16416","article-title":"Doxycycline postexposure prophylaxis and sexually transmitted infections.","volume":"330","author":"Mayer","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"jrv250029r80","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"jrv250029r81","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/cid\/ciz866","article-title":"Doxycycline prophylaxis for bacterial sexually transmitted infections.","volume":"70","author":"Grant","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"jrv250029r82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/sextrans-2024-056208","article-title":"Efficacy of postexposure prophylaxis with doxycycline (doxy-PEP) in reducing sexually transmitted infections: a systematic review and meta-analysis.","volume":"101","author":"Sokoll","year":"2025","journal-title":"Sex Transm Infect"},{"issue":"25","key":"jrv250029r83","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1056\/NEJMoa2304007","article-title":"Doxycycline prophylaxis to prevent sexually transmitted infections in women.","volume":"389","author":"Stewart","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"jrv250029r84","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/jama.2024.24540","article-title":"Doxycycline postexposure prophylaxis to prevent bacterial sexually transmitted infection.","volume":"333","author":"Flores","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"jrv250029r85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","article-title":"CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024.","volume":"73","author":"Bachmann","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"jrv250029r86","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jama.2024.24543","article-title":"Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the International Antiviral Society-USA Panel.","volume":"333","author":"Gandhi","year":"2025","journal-title":"JAMA"},{"issue":"3","key":"jrv250029r88","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/infdis\/jiae381","article-title":"In vitro exposure of Treponema pallidum to subbactericidal doxycycline did not induce resistance: implications for doxycycline postexposure prophylaxis.","volume":"231","author":"Tantalo","year":"2025","journal-title":"J Infect Dis"},{"issue":"2","key":"jrv250029r89","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.44","article-title":"In vitro cultivation of the syphilis spirochete Treponema pallidum.","volume":"1","author":"Edmondson","year":"2021","journal-title":"Curr Protoc"},{"key":"jrv250029r90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1126170","article-title":"Syphilis vaccine: challenges, controversies and opportunities.","volume":"14","author":"\u00c1vila-Nieto","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"jrv250029r91","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.59490","article-title":"Jarisch-Herxheimer reaction after benzathine penicillin g treatment in adults with early syphilis: secondary analysis of a randomized clinical trial.","volume":"8","author":"Dionne","year":"2025","journal-title":"JAMA Netw Open"},{"key":"jrv250029r7","volume-title":"Syphilis","author":"Tudor","year":"2025"},{"key":"jrv250029r30","first-page":"e0010021","article-title":"The laboratory diagnosis of syphilis.","volume-title":"J Clin Microbiol","author":"Satyaputra","year":"2021"},{"key":"jrv250029r2","unstructured":"World Health Organization. Syphilis. Published May 21, 2024. Accessed August 4, 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/syphilis"},{"key":"jrv250029r3","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted infections: surveillance 2023. Published November 12, 2024. Accessed August 4, 2024. https:\/\/www.cdc.gov\/sti-statistics\/annual\/slides.html"},{"key":"jrv250029r4","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Infections National Strategic Plan for the United States: 2021-2025. US Department of Health and Human Services; 2020. Accessed August 4, 2024. https:\/\/www.hhs.gov\/sites\/default\/files\/STI-National-Strategic-Plan-2021-2025.pdf"},{"key":"jrv250029r18","unstructured":"Sosa? L. Update to public health reporting and national notification for syphilis. Accessed October 16, 2024. https:\/\/resources.cste.org\/cste2\/Webinars\/files\/17-ID-11.cleaned.pdf"},{"key":"jrv250029r43","unstructured":"Centers for Disease Control and Prevention. Clinical features of penicillin allergy. April 22, 2024. Accessed January 23, 2025. https:\/\/www.cdc.gov\/antibiotic-use\/hcp\/clinical-signs\/index.html#cdc_hcp_clinical_resources-resources"},{"key":"jrv250029r51","unstructured":"Quest Diagnostics. Syphilis: laboratory support for screening, diagnosis, and monitoring. Published online October 2024. Accessed September 22, 2025. https:\/\/testdirectory.questdiagnostics.com\/test\/test-guides\/CF_Syphilis\/syphilis-laboratory-support-for-screening-diagnosis-and-monitoring?p=td"},{"key":"jrv250029r62","unstructured":"Ghanem? K. Syphilis management conundrums. Presented at: Conference on Retroviruses and Opportunistic Infections (CROI); March 4, 2024; Baltimore, MD. Accessed September 22, 2025. https:\/\/www.croiwebcasts.org\/p\/2024croi\/croi\/26"},{"key":"jrv250029r76","unstructured":"American College of Obstetricians and Gynecologists. Screening for syphilis in pregnancy. April 2024. Accessed October 18, 2024. https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2024\/04\/screening-for-syphilis-in-pregnancy"},{"key":"jrv250029r87","unstructured":"Sankaran? M. Doxy-PEP associated with declines in chlamydia and syphilis in MSM and trans women in San Francisco. Abstract presented at: Conference on Retroviruses and Opportunistic Infections; March 4, 2024; Denver, CO. Accessed September 22, 2025. https:\/\/www.croiwebcasts.org\/p\/2024croi\/croi\/127"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2840085\/jama_chevalier_2025_rv_250029_1764017904.87442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T16:00:32Z","timestamp":1764691232000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2840085"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":91,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025,12,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2025.17362","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}